Evidence map›Paper›PMID 34403470›Full record

ArticleNucleic acids research2021

SpecHap: a diploid phasing algorithm based on spectral graph theory.

Yonghan Yu, Lingxi Chen, Xinyao Miao, Shuai Cheng Li

Abstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chromosome-Level Haplotype Assembly forFrontiers in genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yonghan YuComputer Science, City University of Hong Kong, Kowloon, Hong Kong 999077, China.ORCID 0000-0001-6359-6823
Lingxi ChenComputer Science, City University of Hong Kong, Kowloon, Hong Kong 999077, China.ORCID 0000-0002-5229-7470
Xinyao MiaoComputer Science, City University of Hong Kong, Kowloon, Hong Kong 999077, China.
Shuai Cheng LiComputer Science, City University of Hong Kong, Kowloon, Hong Kong 999077, China.ORCID 0000-0001-6246-6349

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Haplotype phasing plays an important role in understanding the genetic data of diploid eukaryotic organisms. Different sequencing technologies (such as next-generation sequencing or third-generation sequencing) produce various genetic data that require haplotype assembly. Although multiple diploid haplotype phasing algorithms exist, only a few will work equally well across all sequencing technologies. In this work, we propose SpecHap, a novel haplotype assembly tool that leverages spectral graph theory. On both in silico and whole-genome sequencing datasets, SpecHap consumed less memory and required less CPU time, yet achieved comparable accuracy with state-of-art methods across all the test instances, which comprises sequencing data from next-generation sequencing, linked-reads, high-throughput chromosome conformation capture, PacBio single-molecule real-time, and Oxford Nanopore long-reads. Furthermore, SpecHap successfully phased an individual Ambystoma mexicanum, a species with gigantic diploid genomes, within 6 CPU hours and 945MB peak memory usage, while other tools failed to yield results either due to memory overflow (40GB) or time limit exceeded (5 days). Our results demonstrated that SpecHap is scalable, efficient, and accurate for diploid phasing across many sequencing platforms.

Indexed as

AlgorithmsGenomeAmbystoma mexicanumAnimalsBenchmarkingDatasets as TopicDiploidyHaplotypesHigh-Throughput Nucleotide SequencingHumansNanoporesSequence Analysis, DNATime FactorsWhole Genome Sequencing

Identifiers

PMID34403470
PMCPMC8565328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.